2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
4
Brain Neoplasms
4
Prostatic Neoplasms
3
Neoplasms
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Pinealoma
1
Parotid Neoplasms
1
Oligodendroglioma
1
Neuroendocrine Tumors
1
Neuroectodermal Tumors, Primitive
1
Multiple Sclerosis
1
Meningioma
1
Meningeal Neoplasms
1
Medulloblastoma
1
Lymphoma
1
Liver Neoplasms
1
Hypoxia
1
Gynecologic Cancer
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Ependymoma
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Choroid Plexus Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Brain Tumor Adult
1
Interventions
pembrolizumab
1
gadobutrol
1
Standard of Care
1
Radiotherapy
1
Radiation
1
Quality of Life
1
Proton Therapy
1
Practice Guidelines as Topic
1
Physical Examination
1
Patient Reported Outcome Measures
1
Multiparametric Magnetic Resonance Imaging
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lymph Node Excision
1
Limonene
1
Immunotherapy
1
Erlotinib Hydrochloride
1
Drug Therapy
1
Docetaxel
1
Citric Acid
1
Cisplatin
1
Biological Therapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parotid Neoplasms
×
gadobutrol
×
Clear all
NCT02294838
2016-11-28
SPIT
British Columbia Cancer Agency
Phase NA
Unknown
10 enrolled